Hide Message

Updating the Resource Centre Digital Platform

The Business & Human Rights Resource Centre is at a critical point in its development. Our digital platform is home to a wealth of information on business and human rights, but hasn’t had a visual refresh for a number of years.

We will soon be updating the site to improve its usability and better serve the thousands of people that use our site to support their work.

Please take an advance peek at our new look, and let us know what you think!

Thank you,
Alex Guy, Digital Officer

Find Out More Hide Message

South African pharma firms accused of planning to delay patents law reform

Author: Sarah Boseley, Guardian (UK), Published on: 17 January 2014

Drug companies in South Africa have been accused of planning a covert, well-funded campaign to delay the introduction of laws that threaten their profits. Leaked documents show that pharmaceutical companies planned a $450,000 campaign, involving a high-profile consultancy based in Washington, DC, against changes to intellectual property laws that would enable their patents on new medicines to be bypassed in the interests of public health. This would allow the manufacture of cheaper copies of their medicines…Campaigners accused the international drug giants of trying to derail life-saving legislation. The trade body IPASA (Innovative Pharmaceutical Industry Association South Africa), which was coordinating the campaign, said...the plans were no longer going ahead – although it was legitimate for drug companies to promote their views in this way...

Read the full post here